On the occasion of "World Tuberculosis Day", India launches first-of-its-kind global clinical study integrating traditional Ayurveda with modern TB care regimens; another step closer to "TB Mukt Bharat", says Dr Jitendra...

1. At a Glance

• On World TB Day (24 March 2026), India launched a first-of-its-kind global clinical study integrating Ayurveda with modern anti-tuberculosis treatment (ATT) as adjunct therapy, announced by Union MoS (IC) Science & Technology and Earth Sciences Dr Jitendra Singh [S1][S2].
• Joint initiative of the Ministry of Ayush and the Department of Biotechnology (DBT), Ministry of Science & Technology, led by CCRAS (Central Council for Research in Ayurvedic Sciences) [S2].
• Operationalises the "whole-of-science, whole-of-government" approach to TB Mukt Bharat (TB-Free India) and the National TB Elimination Programme (NTEP) [S1][S3].

2. Why in the News

• 24 March 2026: PIB releases announce the multi-centre Ayurveda-as-adjunct-to-ATT clinical trial coinciding with World TB Day [S1][S2].
• Same day, MoHFW/PIB notes India's TB incidence fell 21% (2015–2024) vs global ~12% per WHO Global TB Report 2025 [S3][S4].

3. Background & Evolution

• MoU signed 25 May 2022 between Ministry of Ayush and DBT to advance integrative, evidence-based healthcare — parent framework for this trial [S2].
• Earlier integrative push (2023): Dr Jitendra Singh flagged an "integrated strategy" combining Ayush + modern medicine for TB elimination [S5-implied].
• NTEP (rebranded from RNTCP in 2020) drives India's pledge to eliminate TB by 2025 — five years ahead of SDG 3.3 (2030) [S3].
• Ayurveda-as-adjunct concept builds on CCRAS protocol work on macronutrient supplementation + classical Ayurveda formulations for Rajayakshma (TB analogue) [S2].

4. Core Static Facts

• Study name/objective: Evaluate efficacy, safety, tolerability of an Ayurveda regimen as adjunct to standard ATT, with macronutrient supplementation [S2].
• Lead agency: CCRAS (an autonomous body under Ministry of Ayush) [S2].
• Funding/partner: DBT, Ministry of Science & Technology [S1][S2].
• Design: Multi-centre clinical study [S2].
• Policy umbrella: NTEP under Ministry of Health and Family Welfare; goal TB Mukt Bharat by 2025 [S3].
• NTEP infrastructure (as of 24 Mar 2026): 1,84,726 Ayushman Arogya Mandirs; >9,800 rapid molecular testing facilities; 107 culture & DST labs — world's largest TB diagnostic network [S3].
• WHO Global TB Report 2025 — India: est. 2.71 million people with TB; 25% of global TB cases; 32% of global MDR/RR-TB [S4].
• Decline: TB incidence −21% and TB deaths −28% between 2015–2024 [S3].

5. Multi-Dimensional Analysis

• Scientific / Technological
• First global-scale RCT-style validation of Ayurveda as adjunct (not replacement) to ATT — meets evidence-based medicine standards [S2].
• Aligns with CTRI (Clinical Trials Registry of India) registration norms; advances integrative pharmacology [S2].
• Administrative / Governance
• Convergence model: Ayush + DBT + MoHFW (NTEP) — illustrates "whole-of-government" coordination [S1].
• Tests CCRAS's institutional capacity for large multi-centre trials [S2].
• Social
• TB is a disease of the poor; integrative low-cost adjuncts plus Ni-kshay Poshan Yojana (nutritional support ₹1,000/month, revised 2024) target vulnerable households [S3].
• Geopolitical / Strategic
• India bears 25% of global TB burden — leadership on integrative protocols positions India in WHO End TB Strategy and G20 health diplomacy [S4].
• Reinforces traditional-medicine soft power via WHO Global Centre for Traditional Medicine (Jamnagar, 2022) ecosystem.
• Ethical
• Adjunct design avoids the ethical risk of denying patients proven ATT; informed-consent and DSMB oversight implied by multi-centre design [S2].

6. Recent Developments (last 12-18 months)

• 24 Mar 2026: Launch of Ayurveda–ATT integrative clinical study; PIB statements by Dr Jitendra Singh [S1][S2].
• 24 Mar 2026: PIB note "India Speeding Towards TB Elimination" — 21% incidence drop, 28% mortality drop (2015–2024) [S3].
• Nov 2025: WHO Global TB Report 2025 released; India 25% of global cases, 32% of MDR/RR-TB [S4].
• 2024–25: 100-Day TB Elimination Campaign intensified across high-burden districts [S3].

7. Prelims Hooks

• World TB Day is observed on 24 March (anniversary of Robert Koch's 1882 discovery of M. tuberculosis).
• Ayurveda–TB clinical study led by CCRAS, funded jointly with DBT [S2].
• CCRAS is under the Ministry of Ayush (not MoHFW) [S2].
• DBT is under the Ministry of Science & Technology [S1].
• Trial is an adjunct-to-ATT study (Ayurveda does not replace standard anti-TB drugs) [S2].
• Underlying Ayush–DBT MoU signed on 25 May 2022 [S2].
• NTEP target: eliminate TB by 2025 — 5 years ahead of SDG 3.3 (2030) [S3].
• TB classical name in Ayurveda: Rajayakshma.
• WHO Global TB Report 2025: India = 25% of global TB cases; 32% of global MDR/RR-TB [S4].
• India's TB incidence fell ~21% (2015–2024) vs global average ~12% [S3].
• TB deaths in India down 28% in 2015–2024 [S3].
• India has 1,84,726 Ayushman Arogya Mandirs delivering primary-level TB services [S3].
• 9,800+ rapid molecular testing facilities; 107 culture & DST labs [S3].
• Ni-kshay Poshan Yojana: DBT cash transfer to TB patients for nutritional support.
• WHO Global Centre for Traditional Medicine: located in Jamnagar, Gujarat (est. 2022).

8. Mains Relevance

• GS-II: Health — Government policies & interventions (NTEP, TB Mukt Bharat); Issues relating to development & management of Social Sector/Services (Health).
• GS-III: Science & Technology — indigenisation, integrative medicine, IPR in traditional knowledge.
• Question stems: 1. "Integrating traditional knowledge systems with evidence-based modern medicine is essential to meet India's TB elimination targets." Critically examine in the light of recent Ayush–DBT initiatives. (15 marks) 2. Discuss the structural and epidemiological challenges to achieving TB Mukt Bharat by 2025, with reference to the WHO Global TB Report 2025. (10 marks) 3. Examine the role of CCRAS and the Ministry of Ayush in mainstreaming traditional medicine through scientific validation. (10 marks)

9. Related Topics to Study Next

• National TB Elimination Programme (NTEP) — core scheme delivering the elimination push.
• Ni-kshay Poshan Yojana & Ni-kshay Mitra — nutritional and community-support arms.
• WHO End TB Strategy & SDG 3.3 — global benchmark against which India is measured.
• WHO Global Centre for Traditional Medicine, Jamnagar — institutional anchor for Ayush diplomacy.
• Ayushman Bharat – Health & Wellness Centres / Arogya Mandirs — primary-care delivery layer.
• Clinical Trials Registry of India (CTRI) & New Drugs and Clinical Trials Rules 2019 — regulatory framework.
• Antimicrobial Resistance (AMR) & MDR-TB — overlapping public-health threat.
• National AYUSH Mission (NAM) — funding/structural backbone for Ayush integration.

10. Common Errors / Trap Areas

• Ministry mix-up: Study is led by Ayush + DBT (S&T), not MoHFW; NTEP itself is under MoHFW. Don't conflate.
• Replacement vs adjunct: Ayurveda is being tested as adjunct to ATT — never as a substitute.
• Target year: India's TB elimination target is 2025, not 2030 (SDG date).
• World TB Day date: 24 March (not 24 May like World Malaria-related awareness days).
• CCRAS vs CCRH vs CCRYN: CCRAS = Ayurveda; CCRH = Homoeopathy; CCRYN = Yoga & Naturopathy — all under Ayush.
• WHO Report year: Latest is Global TB Report 2025 (covering 2024 data) — not 2024 report.

11. Sources

• [S1] On the occasion of "World Tuberculosis Day", India launches first-of-its-kind global clinical study… — https://www.pib.gov.in/PressReleasePage.aspx?PRID=2244584 — (tier: 1)
• [S2] Ministry of Ayush and DBT Announce Collaborative Clinical Study on Ayurveda as Adjunct Therapy for Anti-Tuberculosis Treatment — https://www.pib.gov.in/PressReleasePage.aspx?PRID=2244672 — (tier: 1)
• [S3] India Speeding Towards TB Elimination (PIB, 24 Mar 2026) — https://www.pib.gov.in/PressReleasePage.aspx?PRID=2244661 — (tier: 1)
• [S4] WHO Global Tuberculosis Report 2025 — https://www.who.int/teams/global-programme-on-tuberculosis-and-lung-health/tb-reports/global-tuberculosis-report-2025 — (tier: 2)
• [S5] Union Minister Jitendra Singh refers to integrated strategy to achieve 'TB Mukt Bharat' (PIB, 2023) — https://www.pib.gov.in/PressReleasePage.aspx?PRID=1911208 — (tier: 1)